Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
News|Slideshows|June 16, 2016
Migraine Matters: 6 Meeting Highlights
This brief slide show toplines key research from the 58th Annual Scientific Meeting of the American Headache Society, June 1-4, 2016.
Advertisement
The latest scientific and clinical information on headache and migraine was presented at the 58th Annual Scientific Meeting of the American Headache Society in San Diego last week.“Take a Closer Lookâ¦At Migraine” was the theme of this year’s program.This brief slideshow features highlights of recent research findings on migraine diagnosis, treatment, and prevention.
Advertisement
Related to this article
A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
Plasma p-tau217 levels helped estimate 5- and 10-year cognitive impairment risk in older adults without memory or thinking symptoms.
FDA cleared C2N’s PrecivityAD2 blood test to aid Alzheimer disease evaluation in symptomatic adults aged 40 years and older.
A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
3
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
4
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
5